Extended sequential intravenous and oral antimicrobial therapy improves cure rate in postoperative intracranial

Víctor Asensi1,2, Carlos Vázquez-Fernández3, Silvia Suárez-Díaz3

  • 1Infectious Diseases-HIV Unit, Hospital Universitario Central de Asturias, Avenida de Roma s/n, Oviedo, 33011, Spain. vasensia@gmail.com.

BMC Infectious Diseases
|November 26, 2024
PubMed
Abstract

Insights

Extended antimicrobial therapy improves outcomes for postoperative intracranial neurosurgical infections (PINI). A 6-week sequential intravenous and oral treatment regimen enhances cure rates for these serious neurosurgical infections.

Area of Science:

  • Neurosurgery
  • Infectious Diseases
  • Pharmacology

Background:

  • Postoperative intracranial neurosurgical infections (PINI) are infrequent but serious complications.
  • PINI contribute to significant morbidity, mortality, prolonged hospital stays, and increased healthcare costs.
  • Antimicrobial management strategies for PINI require further investigation due to their impact.

Purpose of the Study:

  • To analyze the characteristics and antimicrobial management of PINI.
  • To identify factors associated with cure and survival in patients with PINI.

Main Methods:

  • Retrospective analysis of 162 PINI cases from 2014-2023 across eight Spanish academic hospitals.
  • Data collected on neurosurgical procedures, infection types, causative pathogens, and antimicrobial treatments.
  • Multivariate analysis to determine factors influencing PINI cure and survival.

Main Results:

  • Common PINI include epidural abscess, scalp infections, meningitis, and cranioplasty infections.
  • Gram-negative bacteria and Staphylococcus spp. were the predominant pathogens.
  • An extended 6-week sequential intravenous and oral antimicrobial therapy was associated with increased cure rates (81.5%) but not survival.

Conclusions:

  • Extended antimicrobial therapy, including oral administration post-discharge, is crucial for improving cure rates in PINI.
  • Neurosurgical correction combined with prolonged antimicrobial treatment enhances patient recovery.
  • While improving cure, extended antimicrobial therapy did not significantly impact survival rates in this cohort.